Please login to the form below

Not currently logged in

drug pricing

This page shows the latest drug pricing news and features for those working in and with pharma, biotech and healthcare.

Pfizer, Sanofi and others set to increase US drug prices in 2021

Pfizer, Sanofi and others set to increase US drug prices in 2021

Drug pricing will also be a focus of the incoming President-elect, Joe Biden, who has promised to reduce drug prices in the US. ... One key tenet of Biden’s drug pricing pledge is to allow Medicare to negotiate drug prices directly with pharma companies

Latest news

More from news
Approximately 72 fully matching, plus 197 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 7 fully matching, plus 39 partially matching documents found.

Latest appointments

  • New faces at Lucid Group and ZPB Associates New faces at Lucid Group and ZPB Associates

    Most recently, she worked in the consultancy’s rare diseases division, where is provided crisis management support in pricing/access barriers for an orphan drug.

  • Pfizer’s Emms takes up ABPI presidency Pfizer’s Emms takes up ABPI presidency

    Emms is no stranger to these issues, having served on the ABPI board and taken part in the negotiations over the future of drug pricing in the UK. ... He has not been afraid to criticise the outcomes of these discussions too, saying in November that the

  • Bayer's Martin Hesse moves to Daiichi Sankyo Europe

    Commenting on the environment in which he starts at Daiichi, Hesse said securing the company's profitability and competitiveness in the light of drug pricing interventions will a major challenge.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 8 fully matching, plus 8 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...